{"doi":"10.1016/j.schres.2004.10.010","title":"Thiobarbituric acid reactive substances in the cerebrospinal fluid in schizophrenia","abstract":null,"journal":"Schizophrenia Research","year":2005,"id":653365,"datarank":0.47670807455219194,"base_score":3.1780538303479458,"endowment":3.1780538303479458,"self_citation_contribution":0.47670807455219194,"citation_network_contribution":0.0,"self_endowment_contribution":0.47670807455219194,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":23,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1704760,"name":"Sahebarao P. Mahadik","orcid":null,"position":1,"is_corresponding":false},{"id":1704761,"name":"David L. Garver","orcid":null,"position":2,"is_corresponding":false},{"id":1704759,"name":"Andrew O. Skinner","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Thiobarbituric acid reactive substances in the cerebrospinal fluid in schizophrenia","abstract":null,"is_dataset_classified":null,"base_score":3.1780538303479458,"endowment":3.1780538303479458,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"15927801","pmcid":null,"openalex_id":"https://openalex.org/W2105213195","authors":[],"funders":[],"total_grants":0,"fwci":0.4035,"citation_percentile":0.64509804,"influential_citations":0,"citation_trend":[{"year":2013,"count":2},{"year":2014,"count":3},{"year":2015,"count":1},{"year":2018,"count":1},{"year":2021,"count":1},{"year":2022,"count":1},{"year":2023,"count":1},{"year":2025,"count":1}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0920996404003858?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0920996404003858?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.schres.2004.10.010","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/15927801","host_type":"repository"}],"fields_of_study":["Tryptophan and brain disorders","Neuroscience and Neuropharmacology Research","Neuroinflammation and Neurodegeneration Mechanisms"],"mesh_terms":["Colorimetry","Fatty Acids, Essential","Fatty Acids, Unsaturated","Female","Free Radicals","Humans","Male","Membrane Lipids","Reference Values","Schizophrenia","Synaptic Membranes","Antipsychotic Agents","Lipid Peroxidation","Thiobarbituric Acid Reactive Substances"],"keywords":["TBARS","Schizophrenia (object-oriented programming)","Thiobarbituric acid","Cerebrospinal fluid","Lipid peroxidation","Internal medicine","Endocrinology","Medicine","Chemistry","Psychology","Psychiatry","Oxidative stress"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-10T21:10:25.737188Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}